Structures by: Vederas J. C.
Total: 12
C32H35N3NiO3
C32H35N3NiO3
Journal of medicinal chemistry (2017) 60, 14 6408-6427
a=11.1064(3)Å b=21.5351(6)Å c=12.1674(3)Å
α=90° β=105.0306(9)° γ=90°
C31H32N6NiO3
C31H32N6NiO3
Journal of medicinal chemistry (2017) 60, 14 6408-6427
a=10.0992(3)Å b=20.5006(7)Å c=13.5700(5)Å
α=90° β=90.2639(5)° γ=90°
C14H19NO4S
C14H19NO4S
Biochemistry (2004) 43, 12 3385-3395
a=6.1115(13)Å b=13.323(3)Å c=8.8714(19)Å
α=90.00° β=93.246(4)° γ=90.00°
(1S)-1-phenylethyl (2R)-2-{[(carbamoylamino)oxy]methyl}oxirane-2-carboxylate
C13H16N2O5
Organic & biomolecular chemistry (2018) 16, 7 1126-1133
a=5.9509(12)Å b=7.1789(12)Å c=16.121(4)Å
α=90° β=90.821(18)° γ=90°
(1R)-1-phenylethyl (2S)-2-{[(carbamoylamino)oxy]methyl}oxirane-2-carboxylate
C13H16N2O5
Organic & biomolecular chemistry (2018) 16, 7 1126-1133
a=5.92380(10)Å b=7.17870(10)Å c=16.1585(3)Å
α=90° β=90.8223(8)° γ=90°
C19H30O3
C19H30O3
Organic & Biomolecular Chemistry (2003) 1, 1 50
a=5.5947(9)Å b=9.6504(17)Å c=31.930(6)Å
α=90.00° β=90.00° γ=90.00°
C10H7NO2
C10H7NO2
Chemical Communications (2001) 24 2740
a=5.5390(6)Å b=7.2645(8)Å c=10.4291(11)Å
α=83.673(2)° β=83.789(2)° γ=80.624(2)°
C11H9NO2
C11H9NO2
Chemical Communications (2001) 24 2740
a=6.0008(8)Å b=7.2370(11)Å c=10.9282(16)Å
α=95.403(2)° β=101.029(3)° γ=102.046(3)°
C19H28O3
C19H28O3
Chemical Communications (Cambridge, United Kingdom) (2003) 13 1492-1493
a=5.5364(8)Å b=9.9736(14)Å c=31.173(4)Å
α=90.00° β=90.00° γ=90.00°
C19H30O4
C19H30O4
Organic & Biomolecular Chemistry (2003) 1, 1 50
a=5.5318(11)Å b=9.7123(19)Å c=32.163(7)Å
α=90.00° β=90.00° γ=90.00°
C19H28O3
C19H28O3
Chemical Communications (Cambridge, United Kingdom) (2003) 13 1492-1493
a=5.5364(8)Å b=9.9736(14)Å c=31.173(4)Å
α=90.00° β=90.00° γ=90.00°
C18H24O6
C18H24O6
Journal of the American Chemical Society (2010) 132, 4530-4531
a=8.3124(3)Å b=9.5889(3)Å c=21.4172(6)Å
α=90.00° β=90.00° γ=90.00°